Parametrica Management’s CONMED CNMD Stock Holding History

Parametrica Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-8,780	Closed	-$503K	–	155
2020 Q1	$503K	Buy	+8,780	New	+$810K	0.51%	41

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

Parametrica Management's CNMD Position: Q2 2020 in Review

Parametrica Management sold out of CONMED (CNMD) in Q2 2020, closing a stake of 8,780 shares — an estimated $503K sold.

Parametrica Management first reported a position in CNMD in Q1 2020 and held it in 1 quarter. The position peaked at $503K in Q1 2020. 227 funds tracked by Wall St. Rank hold CNMD as of Q2 2020.

Parametrica Management reported no remaining CONMED position as of Q2 2020 after selling out during the quarter.
Parametrica Management sold 8,780 CONMED shares in Q2 2020, an estimated $503K.
Parametrica Management first reported a position in CONMED in Q1 2020 and held it in 1 quarter.
Parametrica Management's CONMED position peaked at $503K in Q1 2020.
227 funds tracked by Wall St. Rank held CONMED as of Q2 2020.

Based on Parametrica Management's 13F filing for Q2 2020, filed 17 Aug 2020.